Molecular Biology Enzymes and Kits & Reagents Market: Geographical Scenario | Emerging Trends & Technological Advancements

By -

This report studies the molecular biology enzymes and kits & reagents market for the forecast period of 2016 to 2021. This market is expected to reach 12.69 Billion by 2021 from USD 5.77 Billion in 2016, growing at a CAGR of 17.1%.

(EMAILWIRE.COM, May 03, 2017 ) Browse 102 market data Tables and 43 Figures spread through 184 Pages and in-depth TOC on "Molecular Biology Enzymes and Kits & Reagents Market"
http://www.marketsandmarkets.com/Market-Reports/molecular-biology-enzymes-kits-reagents-market-164131709.html
Early buyers will receive 10% customization on this report.

Market Dynamics:

Growth in molecular biology enzymes and kits & reagents market can be attributed to the technological advancements in the life science industry, increased research activities in the pharmaceutical and biotechnology sector, rising incidences of infectious diseases and genetic disorders, and successful completion of human genome project.

On the other hand, privacy issues related to genetic information and unfavorable reimbursement scenario for genetic testing are expected to restraint the molecular biology reagents market growth during the forecast period.

Get The PDF Brochure For This Report@
http://www.marketsandmarkets.com/pdfdownload.asp?id=164131709

Geographical Scenario:

North America is expected to account for the largest share of the molecular biology enzymes and kits & reagents market in 2016. Factors such as increasing research funding in applied markets; rising number of pharmaceutical & biotechnology companies; increasing prevalence of conditions involving molecular diagnostics, backed by reimbursement in the U.S.; and investments into research projects in Canada.

However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. The high growth of this region can be attributed to increasing government interest in biomedical and biotechnology industries in China, presence of bioclusters in China, outsourcing of clinical research activities in China, conferences & meetings in Japan. Growing pharmaceutical industry backed by government initiatives in India, development of bioclusters in India, Korea-U.S. free trade agreement, and initiatives by non-profit organizations in Asia-Pacific.

Download Sample Pages of this Report@
http://www.marketsandmarkets.com/requestsample.asp?id=164131709

Industry Leaders:

The major players in the molecular biology enzymes and kits & reagents market include Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), New England Biolabs, Inc. (U.S.), Promega (U.S.), Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), F. Hoffmann-la Roche Ltd. (Switzerland), Takara Bio Inc. (Japan), QIAGEN N.V. (The Netherlands), and Becton, Dickinson and Company (U.S.)

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more